Cocrystal Pharma, Inc. operates as a biotechnology company. The Company focuses on developing novel antiviral therapeutics for hepatitis, influenza viruses, and noroviruses. Cocrystal Pharma serves patients in the United States.

Current Report (Form 8-K | Period ending 2024-07-18)

Current Report (Form 8-K | Period ending 2024-06-25)

Current Report (Form 8-K | Period ending 2024-06-20)

Current Report (Form 8-K | Period ending 2024-05-13)

Quarterly Report (Form 10-Q | Period ending 2024-03-31)

United States

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating safe and effective branded and generic prescription, and over-the-counter products targeted exclusively for women. The Company develops three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies.

Iterum Therapeutics Public Limited Company operates as a a clinical-stage pharmaceutical company. The Company develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. Iterum Therapeutics serves physicians and patients worldwide.

Kubota Pharmaceutical Holdings Co.,Ltd. operates as a holding company. The company, through its subsidiaries, specializes in identifying and developing therapeutics to treat the ophthalmic disorders. Kubota Pharmaceutical Holdings serves customers worldwide.

Agile Therapeutics, Inc. develops women's healthcare products. The Company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol, as well as progestin-only birth control patch. Agile Therapeutics discovers a pipeline of investigational contraceptive products in the United States.

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company develops, discovers, and commercializes aesthetics and dermatology based products for inflammatory skin diseases, tissue injury, and unwanted light-pigmented hair reduction. Sienna Biopharmaceuticals serves patients in the United States and Italy.

Tricida, Inc. operates as a bio-pharmaceutical company. The Company focuses on the discovery and clinical development of novel therapeutics to address renal, metabolic, and cardiovascular diseases. Tricida serves patients in the United States.

CNBX Pharmaceuticals Inc. operates as a pharmaceutical company. The Company develops cannabinoid-based antitumor drug candidate for the treatment of colorectal cancer based on novel and proprietary formulation. CNBX Pharmaceuticals serves patients in the United States.

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company develops next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. Zynerba Pharmaceuticals serves the healthcare sector and patients in the United States.

Assembly Biosciences Inc. is a biopharmaceutical company. The Company is focused in the field of infectious diseases such as the Hepatitis B virus (HBV) and clostridium difficile (CDAD). Assembly is developing two proprietary platforms: an HBV-cure platform focused on oral drugs with novel direct-acting mechanisms, and an orally-delivered microbiome therapeutics platform for treating CDAD.

Odonate Therapeutics, Inc. operates as a pharmaceutical company. The Company develops an oral chemotherapy drugs for the treatment of cancer. Odonate Therapeutics offers its services worldwide.

Bal Pharma Limited researches and develops bulk drugs and intermediates.

Indofarma Persero Tbk PT manufactures and trades drugs. The Company's products include generic, branded, licensed, and over the counter (OTC) drugs as well as traditional herbs, health food, cosmetics, and supplementary baby food. Through its subsidiaries, Indofarma also produces packaging materials, machinery and equipment, and infrastructure related to pharmaceutical industry.

Choa Pharmaceutical Company manufactures, wholesales, and retails pharmaceutical products including digestives, antibiotics, and nutrition and tonics in a drinkable double neck ampoule and solid dosage forms.

Shenzhen Neptunus Interlong Bio-technique Co.Ltd. engages in the R&D, production, and sales and distribution of biological pharmaceuticals. The Company specializes in gene engineering drugs and preventive biological products.

Shenzhen Neptunus Interlong Bio Tech Co (8329 HK)

Syntara Limited operates as a clinical stage drug development company. The Company develops therapeutic products for blood related cancers. Syntara serves customers in Australia.

Starpharma Holdings Limited is biotechnology company involved in the research, development and commercialization of dendrimer-based for pharmaceutical, life sciences and other applications. The Company's lead product in development is VivaGel, a microbicide gel for women, for the prevention and treatment of bacterial vaginosis adn a range of sexually transmitted diseases.

Guangdong Taiantang Pharmaceutical Co.,Ltd develops, manufactures and sells Chinese pharmaceuticals.  The Company's products include skin type ointments and pills, and cardiovascular drugs.

Guangdong Taiantang Pharmaceuticl (002433 CH)

Qinghai Gelatin Co., Ltd. manufactures and markets Chinese medicines and a series of gelatin products for pharmaceutical, food, photographic film, and industrial use.  The Company also produces hard capsules for pharmaceutical and cosmetic industries, as well as researches and produces biomedical products.

Invion Limited develops pharmaceutical products for the treatment of asthma and smoking cessation.  The Company also is involved in the treatment autoimmune and inflammatory diseases, such as rheumatoid arthritis.

KYUNG NAM PHARM CO., LTD. manufactures and research in the development of pharmaceutical ingredients. The Company provides human placenta ingredients to pharmaceutical manufacturers. It also provides vitamin and cosmetic products through its subsidiaries.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00